OS Therapies to Present at the LD Micro Main Event XVII
OS Therapies Incorporated (OSTX)
Company Research
Source: Business Wire
NEW YORK--(BUSINESS WIRE)--OS Therapies (NYSE American: OSTX) (“OS Therapies” or “the Company”), a clinical-stage immunotherapy and Antibody Drug Conjugate biopharmaceutical company, today announces that Paul Romness, Chief Executive Officer, and Gerald Commissiong, Chief Business Officer, will present a corporate overview at the LD Micro Main Event XVII. The conference is being held on October 28 – 30, 2024 at the Luxe Sunset Boulevard Hotel in Los Angeles.Event:LD Micro Main Event XVII Presentation Date:Tuesday, October 29, 2024 Time:11:30 AM PT Register to watch presentation:https://me24.sequireevents.com/Mr. Romness and Mr. Commissiong will be available for one-on-one meetings with registered investors of the conference.About OS TherapiesOS Therapies is a clinical stage oncology company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. OST-HER2, the Company’s lead asset, is an immunotherapy leveraging
Show less
Read more
Impact Snapshot
Event Time:
OSTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OSTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OSTX alerts
High impacting OS Therapies Incorporated news events
Weekly update
A roundup of the hottest topics
OSTX
News
- OS Therapies Reports Third Quarter 2024 Financial Results and Provides Business UpdateBusiness Wire
- OS Therapies to Present at The Spartan Capital Investor ConferenceBusiness Wire
- Join OS Therapies’ Exclusive Live Investor Webinar and Q&A Session on October 30Business Wire
- OS Therapies Appoints Two Bio-Pharmaceutical Industry Veterans to the Board of DirectorsBusiness Wire
- OS Therapies to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual SummitBusiness Wire
OSTX
Earnings
- 11/15/24 - Miss
OSTX
Sec Filings
- 11/15/24 - Form 8-K
- 11/15/24 - Form 10-Q
- 11/14/24 - Form NT
- OSTX's page on the SEC website